Loading clinical trials...
Loading clinical trials...
X-linked adrenoleukodystrophy (X-ALD) is a hereditary white matter disorder caused by mutations in the ABCD1 gene leading to disturbances in the metabolism of fatty acids. This results in an accumulat...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Leipzig University Medical Center
NCT03047369 · Leukodystrophy, White Matter Disease, and more
NCT02698579 · Cerebral Adrenoleukodystrophy (CALD), Adrenoleukodystrophy (ALD), and more
NCT04687007 · X-linked Adrenoleukodystrophy
NCT03196765 · X-Linked Adrenoleukodystrophy
NCT01594853 · X-linked Adrenoleukodystrophy
Leipzig University Medical Center, Leukodystrophy Outpatient Clinic, Department of Neurology, Leipzig, Germany
Leipzig, Saxony
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions